Nodal, a secreted factor known for its conserved functions in cell-fate specification and the establishment of embryonic axes, is also required in mammals to maintain the pluripotency of the epiblast, the tissue that gives rise to all fetal lineages. Although Nodal is expressed as early as E3.5 in the mouse embryo, its regulation and functions at pre-and peri-implantation stages are currently unknown. Sensitive reporter transgenes for two Nodal cis-regulatory regions, the PEE and the ASE, exhibit specific expression profiles before implantation. Mutant and inhibitor studies find them respectively regulated by Wnt/β-catenin signaling and Activin/Nodal signaling, and provide evidence for localized and heterogeneous activities of these pathways in the inner cell mass, the epiblast and the primitive endoderm. These studies also show that Nodal and its prime effector, FoxH1, are not essential to preimplantation Activin/Nodal signaling. Finally, a strong upregulation of the ASE reporter in implanting blastocysts correlates with a downregulation of the pluripotency factor Nanog in the maturing epiblast. This study uncovers conservation in the mouse blastocyst of Wnt/β-catenin and Activin/ Nodal-dependent activities known to govern Nodal expression and the establishment of polarity in the blastula of other deuterostomes. Our results indicate that these pathways act early on to initiate distinct cellspecification processes in the ICM derivatives. Our data also suggest that the activity of the Activin/Nodal pathway is dampened by interactions with the molecular machinery of pluripotency until just before implantation, possibly delaying cell-fate decisions in the mouse embryo.
t r a c t a r t i c l e i n f o Introduction
Nodal, a TGFβ superfamily member involved in the specification of distinct cell-fates, has conserved functions in the establishment of anterior-posterior (AP) and left-right (LR) polarities in deuterostome embryos (Shen, 2007) . In the mouse, Nodal has also an earlier role in maintaining the undifferentiated status of the epiblast (Camus et al., 2006; Mesnard et al., 2006) , the pluripotent tissue giving rise to all fetal lineages and to the extra-embryonic mesoderm, but how this relates to its conserved cell-fate specification functions is unclear.
Epiblast precursor cells are intermingled with primitive endoderm (PrE) precursor cells in the inner cell mass (ICM) of the E3.5 mouse blastocyst. Between E3.5 and E4.0 these two cell populations start to segregate to form separate layers (Rossant and Tam, 2009 ), a process completed at E4.5 when the blastocyst implants in the uterus. The epiblast, originally composed of apolar cells, becomes organized in an epithelium when the proamniotic cavity forms at E5.0. This correlates with marked changes in its properties. Single E3.5 epiblast cells injected in a host blastocyst can contribute to all fetal lineages of the resulting chimera (Gardner, 1998) , while post-implantation epiblast cells cannot (Rossant, 2008) . Corresponding cultured stem-cells exhibit similar properties: embryonic stem-cells (mESCs) derived from the epiblast of blastocysts can contribute to all fetal lineages ), while epiblast stem-cells (mEpiSCs) derived from the epiblast of E5.5 to E6.5 embryos can differentiate in multiple lineages in vitro, but not in vivo (Tesar et al., 2007) . Markers specific for pre-or post-implantation epiblast typically see their expression either down-regulated or up-regulated around the time of implantation (Pelton et al., 2002) , indicating that at the molecular level a transition takes place in the epiblast even before the formation of the proamniotic cavity.
Pluripotency markers are turned down in Nodal −/− embryos, and the epiblast prematurely undergoes anterior neural differentiation (Camus et al., 2006; Mesnard et al., 2006) . The earliest molecular evidence of this phenotype has been detected at E5.0, suggesting an even earlier requirement for Nodal. Key components of the Activin/ Nodal signaling pathway, such as Nodal, Smad 2 and 3, the co-receptor Cripto and the transcription factor FoxH1, are indeed present in the mouse embryo as early as E3.5 (Camus et al., 2006; James et al., 2005; Mesnard et al., 2006) . Furthermore, Lefty1, a Nodal target gene encoding a Nodal antagonist, is also expressed from E3.5 onward (Takaoka et al., 2006) . Evidence therefore suggests that Nodal signals before implantation. There is however no certainty regarding when, between E3.5 and E5.0, it starts to be required. Interestingly, while the Activin/Nodal signaling pathway is essential to maintain the selfrenewing capacity of mEPiSCs (Brons et al., 2007; Tesar et al., 2007) , it is not to maintain that of mESCs. Four Nodal cis-regulatory elements have been characterized. The NDE is a Notch-responsive element driving Nodal expression in the node as soon as it appears at E7.5 (Adachi et al., 1999; Krebs et al., 2003; Norris and Robertson, 1999; Raya et al., 2003) . The AIE/LSE is contributing to the asymmetrical expression of Nodal in left lateral plate mesoderm (lpm) at E8.5, and may depend on Activin/Nodal signaling (Saijoh et al., 2005; Vincent et al., 2004) . The remaining two elements, the PEE and the ASE, are active in the epiblast prior to the onset of gastrulation (Adachi et al., 1999; Norris and Robertson, 1999 ) (Ben-Haim et al., 2006) . The ASE, like the AIE/LSE, also contributes to the asymmetrical expression of Nodal at E8.5. The ASE is in the first intron of Nodal. It contains two functional FoxH1-Smad2,3 binding motifs and acts as an auto-regulatory element allowing Nodal to amplify its own expression (Norris et al., 2002; Yamamoto et al., 2001 ). An ASE-based reporter transgene may therefore provide a sensor for Activin/Nodal/Smad2,3 signaling. Deletions of the PEE or the ASE result in phenotypes far less severe than that of Nodal −/− embryos and characterized by later AP or LR patterning defects (Norris et al., 2002; Vincent et al., 2003) . These results emphasize the reliance of Nodal on separate regulatory inputs to maintain its expression.
We were interested to study the regulation and functions of Nodal at peri-implantation stages. We generated transgenic lines where the expression of fluorescent proteins was placed under the control of the PEE or the ASE, and found they provided more sensitive tools than was thus far available to study Nodal before and during implantation. We show that Nodal expression and signaling activity in the mouse blastocyst results from an interplay between an ancestral network of interactions known to promote the establishment of axial polarity, and the molecular machinery of pluripotency found in mammals.
Materials and methods

Reporter constructs and transgenesis
The PEE-hsp68p-3nls-d1eGFP, ASE-hsp68p-3nls-d2eYFP and ASE-hsp68p-3nls-d2eCFP constructs contain the PEE or the ASE sequence (Norris and Robertson, 1999) , the Hsp68 promoter and a sequence encoding 3NLS, subcloned within the pd1eGFPN1 the pd2eYFPN1 or pd2eCFPN1 vector (Clontech) respectively. The d1EGFP version of the GFP protein contains two PEST sequences, against one in the d2EYFP and d2ECFP versions of YFP and CFP, to ensure rapid proteasome-mediated degradation, resulting in half-lives of 1 hour and 2 hours respectively in cell culture conditions (Li et al., 1998) . Following appropriate restriction enzyme digestions, DNA constructs were gel-purified and resuspended in Tris 10 mM, EDTA 0.25 mM pH 7.5. Transgenic founders were obtained after microinjection of the constructs into (C57BL/6 X CBA) F2 fertilized eggs (1 or 2 ng/ml in injection buffer).
Mouse breeding and genotyping
The following lines were used: FoxHI (Hoodless et al., 2001 ), ctnnb1 tm2.1Kem/+ (Brault et al., 2001 ) designated β-catenin −/+ thereafter, Apc Min (Su et al., 1992) and Nodal LacZ (Collignon et al., 1996) .
Stable lines carrying the transgenes were maintained on a (C57BL/6 x CBA)F1 background. After immuno-staining, embryos were individually digested and genotyped using Red Extract-N-Amp Kit (Sigma). The Nodal LacZ and FoxH1 mutant alleles were genotyped as previously described (Collignon et al., 1996; Hoodless et al., 2001) . β-catenin mutant and heterozygous embryos were identified using multiplex PCR: 5′-CACCATGTCCTCTGTCTATCC-3′ and 5′-AAGTGAGAGTGAT-GAAAGTTGTT-3′ for the wildtype allele; 5′-CACCATGTCCTCTGTC-TATCC-3′ and 5′-TACACTATTGAATCACAGGGACTT-3′ for the mutant allele. Apc Min mutant and heterozygous embryos were identified using multiplex PCR: 5′-TAAAGACCAGGAAGCCTTGT-3′ and 5′-AATACCTC-GCTCTCTCTCCA-3′ for the wildtype allele; 5′-TTCCACTTTGGCA-TAAGGC-3′ and 5′-TTCTGAGAAAGACAGAAGTTA-3′ for the mutant allele.
Embryo collection
Mice were maintained under a 12-hour light cycle, between 7 am and 7 pm. Embryos used to screen and analyze transgenic lines were obtained from natural matings between transgenic males and Swiss wildtype (wt) females. Preimplantation embryos were flushed from uterine horns with M2 medium (Sigma). When collected for culture they were rinsed in KSOM. Post-implantation embryos were recovered in DMEM containing 10% fetal calf serum and 25 mM Hepes buffer.
Whole mount in situ hybridization, immunostaining and β-galactosidase staining β-galactosidase detection was performed as described by (Whiting et al., 1991) . Whole mount in situ hybridization protocol was adapted from and ) (see supplementary materials and methods). RNA probes were generated from the following plasmids: Nodal exon2-3 and Gdf3 (Levine and Brivanlou, 2006) . For immunofluorescent (IF) detection of GFP, YFP, Nanog and Gata4, embryos were fixed in 4% paraformaldehyde, rinsed in PBST/BSA (PBS, 0.02% Tween, 2% BSA) and permeabilized in PBS/0.5% Triton, and then incubated with the primary antibodies (diluted in PBS, 0.1% Tween, 2% BSA). After successive PBST/BSA washes embryos were incubated with the secondary antibody. Antibodies were as follows: rabbit anti-GFP, 1/ 500-Alexa 488 anti-rabbit, 1/200-Alexa 488 anti-chicken, 1/500-Alexa 568 anti-rabbit, 1/250 (Molecular Probes); chicken anti-GFP, 1/ 1000-rabbit anti-Nanog, 1/250 (abcam); rabbit anti-Gata4, 1/250 (Santa Cruz Biotechnology). Nuclei were stained with Hoechst 33342 and cortical actin was marked with 0.5 μg/ml Alexa 647-conjugated Phalloidin (both Molecular probes).
Inhibition of ALK4/5/7 receptors
Isolated blastocysts were transferred to an 8-well Netwell plate (Costar) with 400 μl of G2v5PLUS (Vitrolife). They were cultured for 14 hours at 37°C/5% CO 2 in the presence of 20, 40, 50, 100 or 200μM SB-431542 (Sigma) in DMSO, to test for dose toxicity and effectiveness. Control embryos were cultured in the presence of the same amount of DMSO. In our hands, treatment with 40 μM SB-431542 was required to significantly decrease the activity of the ASE-YFP transgene. This dose was not toxic for cultured embryos and was thus chosen to perform inhibition experiments.
Imaging and image processing
Acquisitions were performed using confocal microscopes (Leica TCS SP5) and a spinning disk microscope with a Coolsnap HQ2 highresolution camera. The objectives used to acquire E3.5-E5.5, E6.5 and E8.5 embryos were a 40×, a 20× and a 5×, respectively. Acquisition software was LAS AF (Leica) for the SP5 and Metamorph 7 (Universal Imaging) for the Spinning disk. Image stacks were generated using ImageJ software (http://rsbweb.nih.gov/ij/) with the MBF ImageJ for Microscopy collection of plugins by Tony Collins (http://rsbweb.nih. gov/ij/plugins/mbf-collection.html) installed. To count cells, each nuclei was marked in ImageJ using the Paintbrush Tool, and then counted using the "Particle Analysis/3D objects counter" plug-in.
Bio-informatics analysis Detection of conserved regions
A pair of genomic sequences is called alignment-conserved if their optimal alignment has a statistically significant score and the sequences are not repeats. The algorithm employed to comprehensively detect alignment-conserved non-coding regions at the Nodal locus as potential conserved regulatory modules essentially computes an optimal alignment for every pair of 100-bp fragments, comparing mouse to each of the other species. When comparing two sequences of 100 kb the algorithm compares in the order of 10 10 pairs of 100-mers. The statistical evaluation of sequence alignment scores is greatly simplified by this approach as all aligned sequences have the same length.
PSSM scanning procedure Position-specific scoring matrices (PSSMs) from TRANSFAC were applied to the PEE* sequence to search for putative binding sites. 0-order and 3rd-order Markov models were used to evaluate matches found in PEE* against background. The likelihood of binding in each species was evaluated individually and the geometric mean to aggregate likelihoods across species was used. Briefly, sequences were scanned using PSSMs extracted from the TRANSFAC database. A PSSM of length K induces a distribution over K-mers that models binding sites for the transcription factor(s) it represents. Each position is modeled independently in this distribution. The PSSM can be represented as a matrix, P, where P k, b represents the probability of seeing base b at position k in the PSSM. Given a K-mer, W = w 1 ...w K , and using a simple uniform background model, the log odds ratio L(W) between the binding site model (the PSSM) and a uniform background model, [L(W) = K log4 + Σ κ κ-1 logρ κ,w κ + V], can be calculated where V is a prior representing how likely one believe binding to be. V of −4.7 (all logarithms to base 10) was used based on experience analyzing other loci. The mouse sequences were analyzed but the log-odds ratio using information from the human and cow sequences were adjusted. The human and cow sequences were scanned for the TRANSFAC PSSMs independently using the same procedure. The log-odds ratio that there is at least one binding site for each PSSM in each sequence was calculated. Then the log-odds ratio for each putative binding site in the mouse sequences by taking the average of its log-odds ratio with the log-odds ratio that the PSSM binds anywhere in each of the conserved human and cow sequences were adjusted. This heuristic captures the idea that one would expect the binding sites to be conserved across the species. An average was taken rather than a sum, as the sequences were selected for their conservation and are therefore not independent.
Results
We used nuclear destabilized versions of the fluorescent proteins (FPs) GFP, YFP or CFP to obtain a more tractable and dynamic reading of the transgenes' activities (Fig. 1A) .
Validation of PEE-GFP transgenic lines at post-implantation stages
Four out of the nine PEE-GFP lines produced showed a similar GFP expression profile in the epiblast at E5.5 and E6.0, with characteristic proximal and posterior restrictions. This profile was consistent with that obtained with the ASE-deleted Nodal Δ600LacZ allele, and the PEE-LacZ reporter transgene ( Fig. 1 B, C; (Ben-Haim et al., 2006; Norris and Robertson, 1999) . The PEE-GFP line showing the strongest signal was thus picked to investigate PEE activity and regulation. Immunofluorescent (IF) detection of the GFP proved to be a sensitive and efficient method to collect expression data. FP localization experiments presented here were therefore done by IF.
Validation of ASE-FP transgenic lines at post-implantation stages
One out of three ASE-YFP transgenic lines and two out of nine ASE-CFP transgenic lines expressed the FPs at detectable levels and showed patterns consistent with that of the ASE-LacZ transgenic line (Norris and Robertson, 1999) . The fluorescence was detected in the epiblast at E5.25, E5.5 and E6.0 (Figs. 1E; S1A, B; S2D), and transiently in the left lpm at E8.5 ( Fig. 1D ; Figs. S1C, D), tissues where the ASE is known to be active. While β-galactosidase staining is still visible in the left lpm of 12-somite stage Nodal LacZ and ASE-LacZ embryos, destabilized FPs were not detected in this tissue beyond the 5-somite stage, attesting of their rapid degradation (Table S1 ; Fig. S1C 
-F).
No signal was found in the visceral endoderm (VE) of any of the ASE-FP lines (Fig. 1E ). Since intronic sequences containing the ASE were previously reported as driving the expression of Nodal in the VE at pre-gastrulation stages (Adachi et al., 1999; Norris and Robertson, 1999 ) the matter was further investigated using the original ASE-LacZ line. Almost all ASE-LacZ embryos analyzed at E5.5 and E6.0 (n = 7/8 and n = 7/8 respectively; Fig. 1F ; S2A) showed β-galactosidase activity exclusively in the epiblast. Only two embryos showed staining in a few VE cells. We confirmed that E5.5 and E6.0 Nodal LacZ/+ embryos exhibit β-galactosidase activity in the VE covering the embryonic region (Varlet et al., 1997) , while Nodal Δ600LacZ/+ embryos, where the ASE is deleted in the Nodal LacZ allele, lack this activity in the VE ( Fig. 1G , C; S2C). These results demonstrate the ASE is necessary but not sufficient to drive expression in the VE at pre-streak stages, suggesting it synergizes with another sequence element, as yet unidentified, to generate Nodal VE expression. The ASE-YFP transgene was then introduced into Nodal and FoxH1 mutant backgrounds to further its validation (Hoodless et al., 2001) . No expression was detected in E5.5 Nodal −/− embryos (n = 6/6; Fig. 1H ), consistent with previous studies (Brennan et al., 2001) . Similarly, no expression was detected at E5.5 in the absence of FoxH1 (n = 7/7; Fig. 1I ), as reported for the ASE-LacZ transgene at E6.5 (Norris et al., 2002) . Together our results establish that the ASE-YFP transgenic line harbors an adequate reporter for the Nodal/FoxH1-dependent activity of the endogenous ASE.
The transgenes are active at peri-implantation stages
In contrast to post-implantation stages, where direct visualisation of the FPs is possible in both transgenic lines, only the ASE-YFP transgene delivers a robust fluorescent signal at preimplantation stages. Reliable detection of PEE-GFP expression at preimplantation stages requires IF or ISH. For both transgenes, the earliest expression was detected at E3.5, but the theoretical maximum ratio of 50% of fluorescent embryos in litters sired by heterozygous males is only reached at E4.5 (Fig. 2) . Analysis of these ISH and IF results (data not shown) indicates that the two transgenes are activated in a comparable fraction of the embryos at these stages and suggest that the longer half-life of d2EYFP (see Materials and Methods) allows detection of lower expression levels than d1EGFP.
To understand how the PEE and the ASE may contribute to Nodal expression in the ICM, the nascent epiblast and the PrE Takaoka et al., 2006) , the expression of the transgenes was characterized at pre-and peri-implantation stages.
The PEE-GFP transgene marks a subset of ICM and epiblast cells Thirty-seven fluorescent PEE-GFP embryos between E3.5 and E5.0 were distributed in four classes according to their morphology: E3.5; young E4.5; implanted E4.5; E5.0. Their expression patterns were studied by confocal microscopy. The three E3.5 GFP-positive embryos obtained showed only one (Fig. 3A) or two fluorescent ICM cell, close to the mural/polar trophectoderm (TE) junction. Most young E4.5 stage transgenic embryos showed a higher number of GFP-positive cells (between 1 and 4; median = 3), consistently forming a tight group in the epiblast (n = 13/14; Fig. 3B ). This could be due to the activation of the transgene being dependent on a local signal and/or the lineage history of a particular cell, with expressing daughter cells remaining at first in close contact. In older E4.5 embryos, an increase in the number of GFP-positive cells correlates with their distribution spreading out within the epiblast ( Fig. 3C ; n = 12/17). Expression of the PEE-GFP transgene is never detected in the PrE (n = 0/31). The increase in the number of expressing cells could result from the inducing signal gaining in strength and/or more epiblast cells becoming capable of expressing the transgene. By E5.0, all epiblast cells are fluorescent ( Fig. 3D ; n = 3). They exhibit a range of intensities, but the resulting heterogeneity shows no specific pattern.
Wnt/β-catenin signaling is upstream of PEE activity at peri-implantation stages
To investigate what upstream signals are important for the expression of Nodal, we performed an extensive bioinformatics analysis of the DNA sequence separating the transcription start site (TSS) of Nodal from that of the Paladin gene in mouse, human, cow and dog. Every 100 bp fragment in mouse was compared to every 100 bp fragment in the other species using optimal sequence alignments. Two clusters of conserved sequences were identified, and appeared associated to either gene (Fig. S3) . The cluster closest to Nodal comprised four conserved stretches, with the most 5' corresponding to a 125 bp long sequence within the 1.8 kb PEE (Fig. 4A) . Position-specific scoring matrices (PSSMs) from TRANSFAC were applied to this 125 bp sequence to search for putative binding sites (Matys et al., 2003) . An algorithm was used to rank their likelihood of being functional, thus highlighting a number of sites of interest. The best hits were for two LEF/TCF binding sites (Fig. 4B) , which had also been recognized in (Ben-Haim et al., 2006) . This was interesting, as LEF/TCF factors are effectors of the canonical Wnt/β-catenin signaling pathway (Arce et al., 2006) . This pathway acts upstream of the genetic cascade, including Nodal homologues, that establishes the embryonic axis in other vertebrates and in sea-urchin (Agius et al., 2000; Range et al., 2007; Schier, 2001; Stern, 2006) . It was reported that Nodal is expressed in E6.0 β-catenin −/− embryos (Morkel et al., 2003) . We found that the ASE-YFP transgene is also expressed in E5.5 β-catenin −/− embryos (Brault et al., 2001) , attesting that Activin/Nodal signaling is still active in these (Fig. S4A, B) . In contrast, the PEE-GFP transgene was found inactive in E5.25 β-catenin −/− embryos (Fig. S4C, D) , a result consistent with the reported downregulation of a PEE-LacZ transgene in the PS of E6.0 Wnt3 −/− embryos (Ben-Haim et al., 2006) , further demonstrating that Wnt/β-catenin signaling contributes to Nodal regulation via the PEE.
To test the implication of the canonical Wnt pathway in the regulation of the PEE at early stages, PEE-GFP expression was analysed in the context of loss-of-function or gain-of-function mutations for this pathway. First, we found that E4.75 β-catenin −/− embryos do not express the transgene (n = 5; Fig. 4C, D) . This is the earliest defect characterized in β-catenin mutants so far, and a clear indication that PEE activity is dependent on canonical Wnt signaling before implantation. Second, we used the Apc Min mutation in which a truncated form of the adenomatous polyposis coli (Apc) gene prevents the formation of the APC complex, leading to cytoplasmic and nuclear accumulation of β-catenin and constitutive activation of the pathway as early as E4.5 . E4.5 Apc Min/Min embryos harboring the PEE-GFP transgene had more fluorescent epiblast cells than wildtype and heterozygote littermates of a similar size (n = 6; Fig. 4E , F, G), confirming that canonical Wnt signaling regulates the expression of the transgene. Interestingly, while β-catenin accumulates in the epiblast and in the PrE of these embryos ; Fig. S4E, F) , PEE-GFP expression remains restricted to the epiblast. Our results suggest that canonical Wnt signaling regulates Nodal expression in the preimplantation epiblast through the PEE, and that additional interactions are required to restrict PEE activity to the epiblast.
The ASE-YFP marks subsets of cells in the PrE and in the early epiblast
The ASE-YFP transgene is expressed both in the epiblast and in the PrE, and generally shows more diverse expression patterns than the PEE-GFP transgene. To characterize this diversity and its dynamics, a total of eighty-eight fluorescent ASE-YFP embryos, sired by homozygous males, were analyzed. The identity of YFP-positive cells was established, based on embryo morphology and the cells' location. Embryos recovered between E3.25 and E3.75 were all blastocysts showing no evidence of PrE formation. 75% of these embryos had YFP-positive cells in the ICM only (n = 15/20; Fig. 5A ). Embryos recovered between E3.75 and E4.0 were late blastocysts with a visible PrE layer (Plusa et al., 2008) . Most had YFP-positive cells in both the epiblast and the PrE (n = 8/10). This was also the predominant pattern (n = 30/38) in embryos collected between E4.0 and E4.5. YFP-positive cells in the TE, a rare occurrence, were detected either before PrE formation, or later at the abembryonic pole of E4.5 implanting embryos (n = 5/20 and n = 3/38 respectively). The distribution of YFP-positive cells per lineage is shown in Fig. S5A .
To reconstruct in detail the dynamics of the ASE-YFP transgene's expression, we decided to stage the embryos by counting the total cell number (TCN) of each embryo (Fig. S5B) . Although not without caveat, because of apoptosis, the TCN is a more reliable criteria than the time of dissection to evaluate the relative developmental stages of different blastocysts (Copp, 1978; Plusa et al., 2008) . Depending on their TCN embryos were thus assigned to classes 20 cells apart.
In E3.5 blastocysts without morphological evidence of the PrE layer (n = 18), the number of YFP-positive cells in the ICM varied between 1 and 4 (median = 2; Fig. 5B, C) . YFP-positive nuclei could be detected in the PrE layer as soon as it started to form, but the transgene's expression only ever marked a fraction of PrE cells in E4.5 embryos (Fig. 5D-I ). In the epiblast, the YFP is at first present in a small number of nuclei (Fig. 5E-G) , but in implanted E4.5 embryos it tends to mark a majority of epiblast cells (Fig. 5H, I ). An analysis of Nodal expression was conducted by in situ hybridization to allow for comparison. Nodal transcripts were detectable only from the late morula stage (n = 1/18, data not shown) and were consistently observed in ICM cells of early to hatched blastocysts (Fig. 5J-L) . At E4.5 the majority of embryos harbored Nodal expression in both ICM derivatives, with the PrE expression appearing stronger in some cells than in others (Fig. 5M , n = 61/86). A fraction of E4.5 embryos (Fig. 5N , n = 25/86) and all E5.0 embryos (Fig. 5O , n = 12/12) showed expression exclusively in the epiblast, indicating that Nodal is downregulated in the PrE and its derivatives shortly after implantation. Nodal transcripts were however detected again in the VE at E5.25 (Fig. 5P , n = 9/13).
ASE-YFP expression is thus consistent with that of Nodal in the ICM, the epiblast and the PrE, suggesting the likely involvement of the ASE in the regulation of Nodal expression in these tissues. However, like for the PEE-GFP transgene, the heterogeneous expression of the ASE-YFP transgene suggests intrinsic differences between cells within the epiblast or the PrE. To investigate what distinguishes expressing and non-expressing cells we first focused on characterizing the regulation of the ASE-YFP transgene in the blastocyst.
Nodal and FoxH1 are dispensable for the preimplantation expression of the ASE-YFP transgene
Although the ASE-YFP transgene is not expressed in E5.5 Nodal −/− embryos ( Fig. 1H) , it is expressed earlier in these mutants. A majority of the E4.5 Nodal −/− embryos analyzed expressed the transgene in the epiblast (n = 6/8; Fig. 6A, B) , and half of those also showed expression in the PrE, an array of patterns not significantly different from that of wildtype embryos. Similarly, the ASE-YFP transgene was expressed in E4.5 FoxH1 −/− embryos (n = 3/4; Fig. 6C, D) , but not in E5.5 FoxH1 −/− embryos (Fig. 1I) , indicating that the expression of the transgene is not FoxH1-dependent at the earlier stage. These results raised the possibility that the transgene might not depend on TGFβ-related signaling before implantation. E3.5 transgenic embryos were cultured overnight in the presence of 40 μM SB-431542, a pharmacological inhibitor of the type I receptors Alk4, 5 and 7 (Inman et al., 2002) . At this concentration, chosen after preliminary toxicity tests (see Materials and methods), the development of the embryos was not significantly affected, as assessed by TCN counting and Gata4 immunostaining ( Fig. 6I; Fig. S6 ). The treatment nevertheless resulted in a drastic reduction of the proportion of YFP-positive embryos, from 79% to 29%, and the cells that expressed the transgene did so at a lower level than their counterparts in untreated embryos (Fig. 6E-H) . We conclude that, at E4.5, most of the activity of the ASE-YFP transgene is dependent on Activin/Nodal-like TGFβ signaling.
PrE formation and implantation are followed by increased ASE-YFP expression in the epiblast
To analyze the dynamics of the ASE-YFP transgene activity, the distribution of the YFP-positive cell fraction within each TCN class was systematically compared to that of adjacent classes using a MannWhitney non-parametric test (Fig. 7A ). This analysis suggests there are three phases in the activity of the transgene for the range of embryonic size considered. During phases I and II the fraction of YFP-positive cells appears stable (see also Fig. S5B ). Transitions between phases are however marked by an increase in the fraction of YFP-positive cells. Although the transition between phases I and II seems to involve a smaller difference than between phases II and III it is nevertheless statistically significant (α b 0.05). What marks the phase II to phase III transition is a significant increase in the variance of the distributions (α b 0.001).
The study of embryos within each class, as well as previous reports ( Fig. 5B-I ; (Copp, 1978; Plusa et al., 2008) , indicate the observed transitions follow important developmental events, the onset of epiblast and PrE precursors segregation for the first, and the onset of implantation for the second (Fig. 7A ). How these events, which herald drastic changes in the physiology of the embryo, may affect the activity of the Nodal/Activin pathway is currently unclear.
To find out the dynamics of epiblast and PrE subpopulation within YFP-positive cells, twenty-six embryos were co-immunostained for the PrE specific marker Gata4 and the YFP Plusa et al., 2008) (Fig. 7B-F) . In phase I embryos where PrE and epiblast precursors have not yet segregated, double stained nuclei show that YFP-positive cells can belong to the population of committed PrE precursors (Fig. 7B) . The YFP-positive fraction then reaches a peak of only 14% of PrE (Gata4-positive) cells in phase II and declines afterwards, a dynamic consistent with the absence of ASE-YFP expression in the VE, a PrE derivative, by E5.0 (Fig. 7E, F) .
Expression of the ASE-YFP transgene in epiblast cells correlates with Nanog downregulation
Double staining with Gata4 showed that the share of PrE cells within the YFP-positive cell population decreases from 39.5% in phase II to 18.6% in phase III (Fig. 7F) . Concomitantly, ASE-YFP-positive cells become more prominent in the epiblast (Fig. 5I, 6A, C; Fig. S5A ). The pluripotency factor Nanog also displays a heterogeneous expression pattern in the epiblast of E4.5 embryos Plusa et al., 2008) . However, unlike that of ASE-YFP, Nanog expression has been reported to decrease between E3.5 and E5.0 (Chambers et al., 2003; Hart et al., 2004; ). To determine whether there is a correlation between these two dynamics, 25 transgenic embryos were co-immunostained for Nanog and YFP. The dynamics of the Nanogpositive and YFP-positive cell populations appear to go in opposite directions, with the size of the former declining as the embryos develop (Fig. 7J, K) . Strongly double-stained nuclei are detected in the ICM of phase I embryos, suggesting the ASE-YFP transgene marks epiblast precursors as well as PrE precursors (Fig. 7G) . In contrast, only a few weakly double-stained cells are detected in the epiblast of embryos from phases II and III (Fig. 7H, I ). Furthermore, the Nanogpositive and the YFP-positive cell populations in the epiblast become exclusive of each other, exhibiting complementary patterns in individual phase III embryos (Fig. 7H, I , K). We noticed also the presence of cells that express neither of the two markers in the epiblast of peri-implantation embryos (Fig. 7I) . However, such double-negative cells are most apparent in embryos from phase III, where their presence correlates with a decrease in the number of Nanog positive cells and a greater variability in the number of ASE-YFP-positive cells ( Fig. 7A; Fig. S5B) .
Together with the Gata4 data, these results suggest the heterogeneity in the activity of the ASE-YFP transgene does not strictly relate to the establishment of epiblast or PrE identity, but may instead concern the emergence of distinct cell identities within these cell layers.
Discussion
Conservation of canonical Wnt/β-catenin signaling in the mouse blastocyst
The PEE-GFP transgene is expressed from the blastocyst stage onward. Analysis of this expression in β-catenin −/− and Apc Min/Min embryos demonstrates it is dependent on canonical Wnt/β-catenin signaling, and provides for the first time evidence of Wnt/β-catenin activity in the nascent epiblast. Furthermore, the epiblast-specific expression of the transgene in Apc Min/Min mutant embryos indicates other interactions, either inductive in the epiblast and/or repressive in the PrE, are required to generate this pattern. Several ligands and receptors of the canonical Wnt/β-catenin signaling pathway are present in the E3.5-E4.5 blastocyst (Hamatani et al., 2004; Kemp et al., 2005; Wang, 2004) , but its activity also depends on the effectors and antagonists involved. TCF3, a LEF/TCF family member known as a repressor of organizer genes in Xenopus, zebrafish and mouse (Houston et al., 2002; Kim et al., 2000; Merrill et al., 2004) is present at these early stages in the mouse embryo (Tam et al., 2008) . It also acts predominantly as a transcriptional repressor in mESCs, where it is considered a key pluripotency factor (Cole et al., 2008) . Tcf3 knockdown experiments in mESCs elicited upregulation of Nodal expression (Cole et al., 2008) . A hypothesis consistent with the expression profile of the PEE-GFP transgene is that Wnt/β-catenin signaling releases TCF3-mediated repression of the transgene, which is then expressed thanks to an epiblast-specific interaction. Possible activators of the transgene include other members of the LEF/TCF family, Lef1, Tcf1 or Tcf4, which interact with β-catenin to activate transcription (Arce et al., 2006) . However, there is currently no certainty on the presence of either of these factors in E3.5 to E4.5 blastocysts.
Expression of BAT-Gal, a reporter transgene for canonical Wnt signaling containing multimerized LEF/TCF binding sites, is not detected before E5.5 (Kemler et al., 2004; Na et al., 2007) . The earlier expression of the PEE-GFP transgene may result from greater sensitivity of the fluorescent reporter compared to β-galactosidase. It may also result from the interaction of the PEE with factors other than LEF/TCF family members, possibly synergizing with LEF/TCF family members. While our analysis of the conserved PEE sequence focused on two LEF/TCF binding sites, putative binding sites for other transcription factors were identified in their vicinity. Future analysis will tell whether they contribute to PEE-GFP activation.
Early clustering of PEE-GFP expressing cells in the preimplantation epiblast raises the possibility that they respond to a localized, symmetry-breaking, signal. No asymmetrical expression has been reported for the various Wnt ligands expressed in the embryo at this stage. Nuclear β-catenin has however been detected transiently at E4.5, in a single polar TE cell close to the PrE, in 15% of the embryos analyzed . It has not yet been linked to the establishment of later, post-implantation, AP polarity. This data and our results nevertheless suggest the possibility of a Wnt/β-catenindependent symmetry-breaking signal at E4.5. β-catenin loss-offunction and constitutive activation of canonical Wnt signaling both lead to defective proximo-distal patterning, suggesting localized activation of this pathway is important to establish initial asymmetries Huelsken et al., 2000; Morkel et al., 2003) . Nodal signaling is also critical for the proper establishment of AP polarity (Brennan et al., 2001; Mesnard et al., 2006; Yamamoto et al., 2004 ). Yet, Nodal expression appears unaffected from E4.5 in β-catenin mutant embryos (Figs. S4G, H; Morkel et al., 2003) . Furthermore, PEE deletion at the Nodal locus does not affect this process (Vincent et al., 2003) , demonstrating the PEE is not the conduit via which Wnt/β-catenin signaling governs the establishment of the embryonic axes at early stages. On the other hand, the expression of the Nodal co-receptor Cripto is directly under the control of canonical Wnt signaling Morkel et al., 2003) . This situation may share some similarities with that in Xenopus. Although some Xenopus Nodal-related genes harbor numerous LEF/TCF binding sites in their cis-regulatory region, the main fashion in which Wnt/β-catenin signaling polarises Activin/ Nodal activity is via indirect regulation of the production of activin receptor Acvr2a (Hyde and Old, 2000; Martello et al., 2007) . The PEE-GFP transgene will be a valuable tool to dissect further the contribution of Wnt/β-catenin signaling to Nodal regulation and the establishment of AP polarity in the mouse embryo.
Conservation of early TGFβ signaling in the mouse blastocyst
The expression of the ASE-YFP transgene in the blastocyst is unaffected in Nodal −/− or FoxH1 −/− embryos, but drastically reduced after treatment with SB-431542. This strengthens the case for the implication of factors other than Nodal and FoxH1 in Activin/Nodal signaling before implantation. In Xenopus, zebrafish, chick and seaurchin, there is consistent evidence of another TGFβ family member acting upstream of early Nodal expression (Birsoy et al., 2006; Dohrmann et al., 1996; Hagos et al., 2007; Range et al., 2007; Skromne and Stern, 2001) . Vg1 is in Xenopus the prototype of a maternally deposited TGFβ-related ligand that is required to form the organizer and the mesoderm (Birsoy et al., 2006) . Vg1-related molecules of maternal origin identified in Zebrafish and in sea-urchin appear to have similar properties (Dohrmann et al., 1996; Hagos et al., 2007; Range et al., 2007) . Signaling from these factors is transduced by Smad2,3 and therefore contributes to the expression of Nodalrelated genes via the conserved auto-regulatory loop. There are two Vg1-related factors in the mouse, Gdf1 and Gdf3 (Chen et al., 2006; Cheng et al., 2003; Wall et al., 2000) . However, neither of them appears capable of activating the Smad2,3 pathway at physiological concentrations (Andersson et al., 2007; Levine et al., 2009; Tanaka et al., 2007) . Their main effect on Nodal is to enhance its signaling range via the formation of heterodimers (Tanaka et al., 2007) . Gdf3 is expressed in the ICM and in the epiblast of E3.5 to E4. (Albano et al., 1993; Albano and Smith, 1994) . A recent report suggests Activins are responsible for the activation of Smad2/3 signaling in the VE of E5.5 embryos (Yamamoto et al., 2009) . The presence of one of these ligands at peri-implantation stages could explain the early ASE-YFP expression in Nodal −/− mutant embryos.
Origin and significance of ASE-YFP heterogeneous expression
An interesting aspect of ASE-YFP expression is its heterogeneity at early stages. The ASE-YFP transgene can mark both epiblast and PrE precursors, at a time when they appear committed to their fates but have not yet segregated, suggesting Activin/Nodal signaling is not absolutely required to specify these lineages (Plusa et al., 2008) . Restriction of the transgene's expression to a small number of cells in each precursor population suggests instead that Activin/Nodal signaling acts early on to promote the emergence of differences within each tissue layer.
Nodal is expressed in the PrE up to the time of implantation, after which it is downregulated. Expression of the ASE-YFP transgene is only ever detected in a subset of PrE cells, as is the case for Hex, Pem, Lefty1 and Cer1 Takaoka et al., 2006; TorresPadilla et al., 2007) . The PrE gives rise to parietal endoderm and VE. A study of blastocyst outgrowths suggested the involvement of Smad2,3-dependent signaling in the regulation of parietal endoderm formation (Roelen et al., 1998) . A time-lapse study found that the anterior VE at E5.75 contains descendants of E4.75 Cer1-expressing PrE cells that have maintained this expression throughout, arguing for an early specification of their fate . Further lineage and functional studies will thus be necessary to assess how Activin/Nodal signaling affects the allocation of PrE cells to their possible fates.
Contrary to what happens in the PrE, a majority of epiblast cells end up expressing the ASE-YFP transgene, highlighting its usefulness as a marker of the transition undergone by the tissue as a whole during implantation (Chambers et al., 2003; Hart et al., 2004; Pelton et al., 2002) . One hypothesis is that expression of the ASE-YFP transgene marks nascent epiblast cells that have initiated their transition to a distinct status. The Smads activate transcription via chromatin remodeling (Dahle et al., 2010; Ross et al., 2006) , a mode of action possibly unique among transcription factors. This identifies Smads as good candidates for regulating the process that locks in developmental decisions, preventing reversion to a previous status.
The change in a few hours from a predominantly ASE-YFP-negative epiblast to a broadly ASE-YFP-positive one reflects either an increased exposure of epiblast cells to Activin/Nodal signaling and/ or the fact that their capacity to respond to it is itself regulated. Correlation between the gradual elimination of Nanog from the epiblast and increased ASE-YFP expression in this tissue suggests a Nanog-dependent antagonism of Activin/Nodal signaling in Nanogexpressing cells, effective regardless of the ligand involved. This does not necessarily imply a direct interaction between Nanog and components of the signaling pathway. Indeed, the fact that the correlation between Nanog downregulation and ASE-YFP expression is not manifest before a certain stage suggests that other factors are also implicated. However, Nanog harbors some similarity with Smad4 (Hart et al., 2004) , and has been shown to form a complex with pSmad2/3 in hESCs and mEpiSCs, with the effect of dampening the transcriptional activity of the pathway (Vallier et al., 2009a) . Although such an interaction has not been characterized in mESCs yet, Nanog knock-down in mESCs does result in an upregulation of Nodal expression (Sharov et al., 2008; Vallier et al., 2009b) indicating the implication of Nanog in a repression of Activin/Nodal signaling is a recurrent feature of early mammalian development.
Another interesting aspect of the dynamic of ASE-YFP expression is the variability in the number of ASE-YFP-positive cells seen at E4.5 in individual embryos of a comparable size. The mixed genetic background of our embryos may contribute to this variability. It could result also from the ability of individual embryos to respond and to adapt to their changing environment at this stage. So the variability in ASE-YFP expression at E4.5 may reflect how in each embryo the activity of the Activin/Nodal pathway is adjusted in response to its particular circumstances.
The study of the PEE-GFP and ASE-YFP transgenes provides new insights into the activities of the canonical Wnt signaling and Activin/ Nodal signaling pathways at pre-and peri-implantation stages, and shows how these activities contribute to the regulation of early Nodal expression. Interestingly, our transgenes only partially recapitulate this early expression, further highlighting the complexity of Nodal regulation before implantation. Additional studies will establish the contributions of other regulatory sequences and synergistic interactions at the endogenous locus in the generation of Nodal full expression profile.
The transgenes' expression patterns reveal unsuspected heterogeneity in the epiblast and the primitive endoderm. Lineage studies combined with the use of the transgenes will show how this heterogeneity relates to the emergence of later cell identities.
Our results indicate that the activity of the Activin/Nodal signaling pathway may be restrained by the molecular machinery of pluripotency. This interaction could delay the action of the Activin/Nodal pathway in cell-fate specification in the epiblast until implantation. The ASE-YFP and PEE-GFP transgenes will be useful tools to investigate the mechanisms promoting epiblast maturation in vivo, and to compare them with processes underlying the early steps of differentiation in mESCs.
Supplementary materials related to this article can be found online at doi:10.1016/j.ydbio.2010.10.036.
